Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers

Elizabeth Page, Elizabeth Bancroft, Mark N. Brook, Melissa Assel, Mona Hassan Al Battat, Sarah Thomas, Natalie Taylor, Anthony Chamberlain, Jennifer Pope, Holly Ní Raghallaigh, D. Gareth Evans, Jeanette Rothwell, Lovise Mæhle, Eli Marie Grindedal, Paul A. James, Lyon Mascarenhas, Joanne McKinley, Lucy Side, Tessy Thomas, Christi J. van Asperen, Hans F. A. Vasen, Lambertus A. Kiemeney, Janneke Ringelberg, Thomas D. Jensen, Palle Jørn Sloth Osther, Brian T. Helfand, Elena Genova, Rogier A. Oldenburg, Cezary Cybulski, Dominika Wokołorczyk, Kai‐Ren Ong, Camilla Huber, Jimmy Lam, Louise Taylor, Mónica Salinas, Lídia Feliubadaló, Jan C. Oosterwijk, Wendy van Zelst-Stams, Jackie Cook, Derek J. Rosario, Susan M. Domchek, Jacquelyn M. Powers, Saundra S. Buys, Karen O’Toole, Margreet G.E.M. Ausems, Rita K. Schmutzler, Kerstin Rhiem, Louise Izatt, Vishakha Tripathi, Manuel R. Teixeira, Marta Cardoso, William D. Foulkes, Armen Aprikian, Heleen van Randeraad, Rosemarie Davidson, Mark Longmuir, Mariëlle Ruijs, Apollonia T.J.M. Helderman van den Enden, Muriel A. Adank, Rachel Williams, Lesley Andrews, Declan G. Murphy, Dorothy Halliday, Lisa Walker, Annelie Liljegren, Stefan Carlsson, Ashraf Azzabi, Irene Jobson, Catherine Morton, Kylie Shackleton, Katie Snape, Helen Hanson, Marion Harris, Marc Tischkowitz, Amy Taylor, Judy Kirk, Rachel Susman, Rakefet Chen‐Shtoyerman, Allan D. Spigelman, Nicholas Pachter, Munaza Ahmed, Teresa Ramón y Cajal, Janez Žgajnar, Carole Brewer, Neus Gadea, Angela F. Brady, Theo van Os, David Gallagher, Oskar T. Johannsson, Alan Donaldson, Julian Barwell, Nicola Nicolai, Eitan Friedman, Elias Obeid, Lynn Greenhalgh, Vedang Murthy, Lucia Copáková, Sibel Saya, John McGrath, Peter Cooke

European Urology · 2019

Read source ↗ All evidence

Summary

We demonstrate that after 3 yr of prostate-specific antigen (PSA) testing, we detect more serious prostate cancers in men with BRCA2 mutations than in those without these mutations. We recommend that male BRCA2 carriers are offered systematic PSA screening.

Source type: Peer-reviewed study
DOI: 10.1016/j.eururo.2019.08.019
Catalogue ID: SNmohbaxkf-7ivwy8

Pulse AI · ask about this record

Dig deeper with Pulse AI.

Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.

How does this finding apply in a UK context?→What are the most cited records on this topic?→